HOME >> MEDICINE >> NEWS
Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease,,Inhibitors

Geneva, Switzerland -- In the first large-scale study of HIV treatment among the urban poor, University of California San Francisco AIDS researchers have found that very few of the HIV-infected poor receive drugs to combat the virus. Of those who do take anti-retroviral drugs, the researchers found a range of how well the patients adhered to their drug-taking regimens, ranging from 24 to 100 percent of prescribed levels. If subjects missed more than 10 percent of their drugs, the HIV treatment became ineffective.

The research project, called the REACH study for "Research in Access to Care in the Homeless," was started in response to concerns that the urban poor may develop resistant strains of HIV as a result of not adhering to their therapy. The UCSF team looked at how many of these people who were HIV-infected received therapy, how well they adhered to their regimens, and how the virus responded. David Bangsberg, MD, MPH, assistant professor of medicine at the UCSF AIDS Program at San Francisco General Hospital, was medical director of the study. He presented the research findings here today (July 1) at the 12th World AIDS Conference.

"This is the first study of anti-retroviral use in a population that makes up a growing portion of the HIV epidemic," said Andrew Moss, PhD, professor of epidemiology and medicine at UCSF and principal investigator. "Poor people are increasingly the main high-risk group for HIV."

Bangsberg said, "Most people think studies can't be done with the homeless because they are hard to keep track of. We found that to be untrue. Of 153 people in the study, we know where 151 of them are now, after more than a year." The UCSF team identified participants for the research project in free food lines, homeless shelters and low-income hotels and tested them for HIV infection. For those HIV-positive people on protease inhibitors, the researchers looked at three measures of adherence: self-report, random pill counts, and a digital
'"/>

Contact: Mitzi Baker
mabaker@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
1-Jul-1998


Page: 1 2 3

Related medicine news :

1. Eight New Hartford doctoral fellows in Geriatric Social Work selected
2. Eighty five percent of practice nurses are underestimating the prevalence of insulin resistance in type 2 diabetes patients
3. UCSF And Eight Other Medical Centers Chosen For National Cancer Institutes Pediatric Brain Tumor Consortium
4. Express Scripts 1999 drug trend report: Seniors hit hardest by record 17.4-Percent prescription drug spending increase
5. New Study Finds Blacks Face 38 Percent Higher Stroke Risk
6. Osteoporosis Drug Evista (Raloxifene) Cuts Newly Diagnosed, Invasive Breast Cancer Risk By More Than 60 Percent
7. Study Finds Incidence Of Stroke Over 40 Percent Higher Than Previously Stated Figures
8. Rats Receiving Ginkgo Biloba Learn Quicker, Live 20 Percent Longer Than Controls, UB Study Finds
9. Congress of Neuological Surgeons meets in San Francisco
10. American Academy of Neurology presents 56th Annual Meeting in San Francisco, April 24 - May 1, 2004
11. NIH funds new brain imaging center at San Francisco VA Medical Center

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from ... primary eye care practitioners on the latest breakthroughs in the prevention, diagnosis and ... Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer ...
(Date:1/17/2017)... ... , ... Neil H. Greco Insurance Agency, a northern New Jersey firm that ... launching a charity drive to raise awareness of heart disease and promote habits that ... and is responsible for 1 in every 4 deaths at the national level each ...
(Date:1/17/2017)... ... ... Livionex, Inc., a Silicon Valley healthcare company focused on treating biofilms and ... gel that shows significant reduction in plaque levels and gum inflammation and bleeding when ... at the Beckman Laser Institute at UC Irvine and has been published in Dentistry, ...
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers ... has announced the latest beneficiary of their thriving community involvement program. The current ... to fulfilling the dreams of terminally ill patients. Donations to this worthy cause ...
(Date:1/17/2017)... ... ... Today, FloSports , a global leader in live digital sports and original ... long-term extension of their media partnership. The partnership, which began in 2013, will now ... events exclusively on FloWrestling.com as well as usage of the FloArena meet management software ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Angel MedFlight Worldwide Air Ambulance is ... Kelly as the keynote speaker at the American ... Washington D.C. April 20-23. Kelly, a ... morning, April 21 at the Gaylord National Resort.  More ... are expected to attend the annual conference. Angel MedFlight ...
(Date:1/17/2017)... , Jan. 17, 2017  Market Research Future published a Half ... Market is expected to reach USD 33.6 million during the period ... Market Highlights ... Global Endoscopy Devices Market has been examined as a swiftly growing ... is huge demand for endoscopy device in various regions.  The increasing ...
(Date:1/17/2017)... 17, 2016  Attorney Advertising -- Bronstein, Gewirtz & Grossman, ... Anthera Pharmaceuticals, Inc. ("Anthera" or the "Company") (NASDAQ: ... and assist the investigation by visiting the firm,s site: ... certain of its officers and/or directors have violated Sections 10(b) ... ...
Breaking Medicine Technology:
Cached News: